BIOPORTO A/S financials
BIOPORTO A/S
5299004SWFL5JAN4W830 | Line item | 2026 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | DKK 16.3M | DKK 40.3M | DKK 18.3M |
| Cost of sales | DKK 5.3M | DKK 9.9M | DKK 6.3M |
| Gross profit | DKK 11.1M | DKK 30.4M | DKK 12.0M |
| Administrative expenses | DKK 19.4M | DKK 38.9M | DKK 18.3M |
| Operating profit (EBIT) | DKK 15.6M | -DKK 86.1M | -DKK 49.1M |
| Finance costs | DKK 1.3M | DKK 2.1M | DKK 2.2M |
| Profit before tax | DKK 15.2M | -DKK 87.6M | -DKK 50.9M |
| Income tax expense | -DKK 3.4M | -DKK 5.5M | -DKK 5.4M |
| Profit for the year | DKK 18.6M | -DKK 82.1M | -DKK 45.5M |
| Total comprehensive income | DKK 18.0M | -DKK 79.8M | -DKK 42.9M |
| Per share | |||
| Basic EPS | DKK 0.04 | DKK -0.18 | DKK -0.10 |
| Free cash flow / share | DKK -0.08 | DKK -0.17 | DKK -0.09 |
| Cash flow statement | |||
| Cash generated from operations | -DKK 36.9M | -DKK 82.7M | -DKK 41.2M |
| Net cash from operating activities | -DKK 36.7M | -DKK 77.1M | -DKK 41.2M |
| Net cash from investing activities | DKK 59.1M | DKK 1.3M | -DKK 1.4M |
| Purchase of PP&E (capex) | DKK 0 | DKK 0 | DKK 1.4M |
| Net cash from financing activities | -DKK 1.9M | DKK 71.9M | DKK 30.9M |
| Lease liability payments | DKK 1.9M | DKK 3.8M | DKK 1.9M |
| Net change in cash | DKK 20.5M | -DKK 3.9M | -DKK 11.7M |
| Balance sheet | |||
| Total assets | DKK 109.3M | DKK 93.2M | — |
| Non-current assets | DKK 9.8M | DKK 8.2M | — |
| Property, plant & equipment | DKK 1.3M | DKK 1.5M | — |
| Right-of-use assets | DKK 3.9M | DKK 4.8M | — |
| Current assets | DKK 99.4M | DKK 85.0M | — |
| Inventories | DKK 5.0M | DKK 9.2M | — |
| Trade & other receivables | DKK 7.7M | DKK 9.4M | — |
| Cash & equivalents | DKK 74.4M | DKK 54.9M | — |
| Total equity | DKK 82.4M | DKK 63.0M | DKK 57.2M |
| Non-current liabilities | DKK 2.5M | DKK 4.0M | — |
| Lease liabilities (non-current) | DKK 2.5M | DKK 4.0M | — |
| Current liabilities | DKK 24.3M | DKK 26.1M | — |
| Lease liabilities (current) | DKK 3.3M | DKK 3.5M | — |
| Derived metrics | |||
| Free cash flow | -DKK 36.7M | -DKK 77.1M | -DKK 42.5M |
| Operating margin | 95.7% | -213.7% | -269.0% |
| Net margin | 114.0% | -203.8% | -249.3% |
| Return on equity | 22.6% | -130.3% | -79.6% |
| Cash conversion ratio | -1.97× | 0.94× | 0.90× |
| Capex coverage | — | — | -30.09× |
| Other reported items | |||
| Accruals Classified As Current | DKK 11.2M | DKK 8.6M | — |
| Adjustments For Decrease Increase In Inventories | DKK 4.6M | -DKK 4.9M | -DKK 202.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | DKK 1.7M | -DKK 1.2M | DKK 1.2M |
| Adjustments For Depreciation and Amortisation Expense | DKK 1.2M | DKK 2.5M | DKK 1.3M |
| Adjustments For Increase Decrease In Trade Account Payable | -DKK 4.2M | DKK 2.7M | -DKK 936.0K |
| Adjustments For Sharebased Payments | DKK 1.4M | -DKK 637.0K | -DKK 454.0K |
| Current Finance Lease Receivables | DKK 975.0K | DKK 1.1M | — |
| Current Tax Assets Current | DKK 6.5M | DKK 6.8M | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | DKK 197.0K | -DKK 919.0K | -DKK 194.0K |
| Equity and Liabilities | DKK 109.3M | DKK 93.2M | — |
| Finance Costs Paid Classified As Operating Activities | DKK 166.0K | DKK 205.0K | DKK 69.0K |
| Finance Income | DKK 834.0K | DKK 511.0K | DKK 349.0K |
| Finance Income Received Classified As Operating Activities | DKK 0 | DKK 347.0K | DKK 143.0K |
| Financial Assets | DKK 4.5M | DKK 1.7M | — |
| Gains Losses On Exchange Differences On Translation Before Tax | -DKK 579.0K | DKK 2.3M | DKK 2.6M |
| Income Taxes Refund Classified As Operating Activities | DKK 316.0K | DKK 5.4M | DKK 0 |
| Increase Decrease Through Sharebased Payment Transactions | DKK 1.4M | — | -DKK 454.0K |
| Intangible Assets Other Than Goodwill | DKK 69.0K | DKK 138.0K | — |
| Issue of Equity | — | — | DKK 33.5M |
| Issued Capital | DKK 495.1M | DKK 495.1M | — |
| Liabilities | DKK 26.8M | DKK 30.2M | — |
| Noncurrent Finance Lease Receivables | DKK 0 | DKK 393.0K | — |
| Other Adjustments To Reconcile Profit Loss | -DKK 59.8M | DKK 2.2M | DKK 1.2M |
| Other Comprehensive Income | -DKK 579.0K | DKK 2.3M | DKK 2.6M |
| Other Current Receivables | DKK 753.0K | DKK 1.2M | — |
| Other Operating Income Expense | DKK 54.1M | DKK 0 | DKK 0 |
| Payments For Share Issue Costs | DKK 0 | DKK 1.1M | DKK 735.0K |
| Prepayments | DKK 2.9M | DKK 2.3M | — |
| Proceeds From Issuing Shares | DKK 0 | DKK 76.9M | DKK 33.5M |
| Research and Development Expense | DKK 16.4M | DKK 50.5M | DKK 29.6M |
| Reserve of Exchange Differences On Translation | DKK 645.0K | DKK 1.2M | — |
| Restricted Cash and Cash Equivalents | DKK 1.1M | DKK 0 | — |
| Retained Earnings | -DKK 413.3M | -DKK 433.3M | — |
| Sales and Marketing Expense | DKK 13.7M | DKK 27.2M | DKK 13.1M |
| Share Issue Related Cost | — | — | DKK 735.0K |
| Trade and Other Current Payables To Trade Suppliers | DKK 9.8M | DKK 14.0M | — |
Every line item above is a fact tagged in BIOPORTO A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.